GLNBX
Price
$21.66
Change
-$0.02 (-0.09%)
Updated
Aug 8 closing price
Net Assets
71.48M
SCWCX
Price
$59.00
Change
-$0.04 (-0.07%)
Updated
Aug 8 closing price
Net Assets
79.34B
Interact to see
Advertisement

GLNBX vs SCWCX

Header iconGLNBX vs SCWCX Comparison
Open Charts GLNBX vs SCWCXBanner chart's image
MFS Global New Discovery B
Price$21.66
Change-$0.02 (-0.09%)
VolumeN/A
Net Assets71.48M
American Funds SMALLCAP World C
Price$59.00
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets79.34B
GLNBX vs SCWCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GLNBX vs. SCWCX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLNBX is a Buy and SCWCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCWCX has more cash in the bank: 79.3B vs. GLNBX (71.5M). SCWCX pays higher dividends than GLNBX: SCWCX (0.04) vs GLNBX (0.00). GLNBX was incepted earlier than SCWCX: GLNBX (14 years) vs SCWCX (24 years). GLNBX (2.56) is less costly to investors than SCWCX (1.78). GLNBX is a more actively managed with annual turnover of: 37.00 vs. SCWCX (32.00). SCWCX has a lower initial minimum investment than GLNBX: SCWCX (250) vs GLNBX (1000). SCWCX annual gain was more profitable for investors over the last year : 11.75 vs. GLNBX (9.67). GLNBX return over 5 years is better than : 9.56 vs. SCWCX (7.41).
GLNBXSCWCXGLNBX / SCWCX
Total Expense Ratio2.101.78118%
Annual Report Gross Expense Ratio2.561.78144%
Fund Existence14 years24 years-
Gain YTD9.1737.964115%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets71.5M79.3B0%
Annual Yield % from dividends0.000.04-
Returns for 1 year9.6711.7582%
Returns for 3 years24.3422.24109%
Returns for 5 years9.567.41129%
Returns for 10 years43.8232.22136%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVLA40.901.85
+4.74%
Palvella Therapeutics Inc
AIZ203.271.46
+0.72%
Assurant
IGMS1.27N/A
N/A
IGM Biosciences
RELI1.02-0.01
-0.97%
Reliance Global Group Inc.
ODP19.41-0.22
-1.12%
ODP Corp (The)